Narayana Hrudayalaya Stock Rises on Strong Q2 Results; Analysts Maintain BUY with Rs 2,100 Target

Overview

Prabhudas Lilladher's research report highlights Narayana Hrudayalaya's robust Q2FY26 performance, with EBITDA up 32% YoY to Rs 4.1bn, beating estimates by 8%. The company's India and Cayman operations showed strong growth, and losses in the insurance segment reduced. Management confirmed aggressive expansion plans, including adding 1,500 beds over three years. Analysts maintain a 'BUY' rating and a price target of Rs 2,100 per share.